STAT3 and diabetes mellitus: The ratio of phosphorylated signal transducer and activator of transcription 3 (pSTAT3) to signal transducer and activator of transcription 3 (STAT3) (Figure 5b) were significantly higher in empagliflozin-treated and liraglutide-treated DM groups than in the DM group.